S100B protein, cerebral ultrasound and magnetic resonance imaging patterns in brain injured preterm infants

• Published in: Clinical chemistry and laboratory medicine Vol. 59; no. 9; p. 1527
• Main Authors: Gasparroni, Giorgia, Graziosi, Alessandro, Bersani, Iliana, Caulo, Massimo, Moataza, Bashir, Aboulgar, Hanna, Mufeed, Hala, Iskander, Iman, Kornacka, Maria, Gruzfeld, Darek, Dotta, Andrea, Savarese, Immacolata, Chukhlantseva, Natalia, Tina, Lucia Gabriella, Nigro, Francesco, Livolti, Giovanni, Galvano, Fabio, Di Battista, Caterina, D'Adamo, Ebe, Primavera, Adele Patrizia, Lapergola, Giuseppe, Conte, Mariangela, Salomone, Rita, Perrotta, Marika, Panichi, Daniele, Levantini, Gabriella, Catenaro, Milena, Strozzi, Chiara, Maconi, Antonio, Centini, Giacomo, Chiarelli, Francesco, D'Antonio, Francesco, Gavilanes, Danilo A W, Gazzolo, Diego
• Format: Journal Article
• Language: English
• Published: Germany 26-08-2021
• Subjects: Brain - diagnostic imaging; Case-Control Studies; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases - diagnosis; Magnetic Resonance Imaging; S100 Calcium Binding Protein beta Subunit; magnetic resonance imaging; cerebral ultrasound; intraventricular hemorrhage; S100B; preterm infants
• ISSN: 1437-4331
• DOI: 10.1515/cclm-2021-0278

The early detection of preterm infants (PI) at risk for intraventricular hemorrhage (IVH) and neurological sequelae still constitutes an unsolved issue. We aimed at validating the role of S100B protein in the early diagnosis and prognosis of IVH in PI by means of cerebral ultrasound (CUS) and magnetic resonance imaging (MRI) today considered standard of care procedures.
We conducted an observational case-control study in 216 PI of whom 36 with IVH and 180 controls. Standard clinical, laboratory, radiological monitoring procedures and S100B urine measurement were performed at four time-points (first void, 24, 48, 96 h) after birth. Cerebral MRI was performed at 40-42 weeks of corrected gestational age.
Elevated (p<0.001, for all) S100B levels were observed in the IVH group at all monitoring time-point particularly at first void when standard monitoring procedures were still silent or unavailable. S100B measured at first void correlated (p<0.001) with the grade of hemorrhage by means of CUS and with the site and extension of neurological lesion (p<0.001, for all) as assessed by MRI.
The present results showing a correlation among S100B and CUS and MRI offer additional support to the inclusion of the protein in clinical daily management of cases at risk for IVH and adverse neurological outcome. The findings open the way to further investigations in PI aimed at validating new neurobiomarkers by means of S100B.